COc1ccccc1C(O)[C@@H]1C[C@@H]2[C@H]3CC[C@@](C)([C@@H]2O1)C3(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?